Goldman Sachs Maintains Neutral on RH, Lowers Price Target to $224

Goldman Sachs analyst Kate McShane maintains RH (NYSE:RH) with a Neutral and lowers the price target from $262 to $224.

Goldman Sachs analyst Kate McShane maintains RH (NYSE:RH) with a Neutral and lowers the price target from $262 to $224.

Total
0
Shares
Related Posts
Read More

Nvidia Bolsters AI Leadership with Investment in Arm Holdings, Eyes Future Growth in Semiconductor Industry

Nvidia's investment portfolio includes stakes in Arm Holdings, SoundHound AI, and Recursion Pharmaceuticals. Despite failed acquisition, Arm's market valuation has soared to $130 billion. Significant role in AI and potential growth in various sectors. Other investments in Nano-X Imaging and TuSimple.

ARM